Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022).
Salvador Domènech-MontoliuJoan Puig-BarberaGema Badenes-MarquesMaría Gil-FortuñoAlejandro Orrico-SanchezMaría Rosario Pac-SaOscar Perez-OlasoDiego Sala-TrullManuel Sanchéz-UrbanoAlberto Arnedo-PenaPublished in: Vaccines (2023)
Long COVID was prevalent in a significant portion of those who contracted COVID-19, underscoring the need for sustained follow-up and therapeutic strategies. Vaccinations, notably the booster dose, had a substantial beneficial effect on long-term infection outcomes, affirming the vaccination's role in mitigating SARS-CoV-2 infection consequences.